Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy.
J Floege, … , W G Couser, K M Koch
J Floege, … , W G Couser, K M Koch
Published December 1, 1995
Citation Information: J Clin Invest. 1995;96(6):2809-2819. https://doi.org/10.1172/JCI118351.
View: Text | PDF
Research Article Article has an altmetric score of 3

Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy.

  • Text
  • PDF
Abstract

Podocyte injury is believed to contribute to glomerulosclerosis in membranous nephropathy. To identify the factors involved, we investigated the effects of basic fibroblast growth factor (bFGF), a cytokine produced by podocytes, on rats with membranous nephropathy (passive Heymann nephritis [PHN]). All rats received a daily i.v. bolus of 10 microg bFGF or vehicle from days 3-8 after PHN induction. In proteinuric PHN rats on day 8, bFGF injections further increased proteinuria. Podocytes of bFGF-injected PHN rats showed dramatic increases in mitoses, pseudocyst formation, foot process retraction, focal detachment from the glomerular basement membrane, and desmin expression. bFGF injections in PHN rats did not alter antibody or complement deposition or glomerular leukocyte influx. bFGF-injected PHN rats developed increased glomerulosclerosis when compared with control PHN rats. Also, bFGF induced proteinuria and podocyte damage in rats injected with 10% of the regular PHN-serum dose. None of these changes occurred in bFGF-injected normal rats, complement-depleted PHN rats or rats injected with 5% of the regular PHN serum dose. These divergent bFGF effects were explained in part by upregulated glomerular bFGF receptor expression, induced by PHN serum. Thus, bFGF can augment podocyte damage, resulting in increased glomerular protein permeability and accelerated glomerulosclerosis. This bFGF action is confined to previously injured podocytes. Release of bFGF from glomerular sources (including podocytes themselves) during injury may represent an important mechanism by which podocyte damage is enhanced or becomes self sustained.

Authors

J Floege, W Kriz, M Schulze, M Susani, D Kerjaschki, A Mooney, W G Couser, K M Koch

×

Total citations by year

Year: 2023 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1994 Total
Citations: 1 5 1 1 4 6 5 5 2 3 4 4 2 5 1 3 2 5 5 6 4 9 6 11 5 9 2 3 119
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (119)

Title and authors Publication Year
Fibroblast Growth Factor 2 Is Produced By Renal Tubular Cells to Act as a Paracrine Factor in Maladaptive Kidney Repair After Cisplatin Nephrotoxicity.
Hu X, Ma Z, Li S, Wen L, Huo Y, Wu G, Manicassamy S, Dong Z
Laboratory Investigation 2023
Cell death mechanisms involved in cell injury caused by SARS‐CoV‐2
MM da Silva, AS de Lucena, S de Sá Leitão Paiva Júnior, VM Carvalho, PS de Oliveira, MM Rosa, MJ de Melo Rego, MG da Rocha Pitta, MC Pereira
Reviews in Medical Virology 2021
Association of circulating fibroblast growth factor-2 with progression of HIV-chronic kidney diseases in children
PE Ray, J Li, JR Das, J Yu
Pediatric Nephrology 2021
Circulating Fibroblast Growth Factor-2 precipitates HIV-nephropathy in mice
JR Das, M Jerebtsova, P Tang, J Li, J Yu, PE Ray
Disease models & mechanisms 2021
Dynamic changes of podocytes caused by fibroblast growth factor 2 in culture
E Yaoita, M Nameta, Y Yoshida, H Fujinaka
Cell and Tissue Research 2021
The Multiple Roles of Fibroblast Growth Factor in Diabetic Nephropathy
J Deng, Y Liu, Y Liu, W Li, X Nie
Journal of inflammation research 2021
The potential role of mast cells and fibroblast growth factor-2 in the development of hypertension-induced renal damage
S Stanchev, B Landzhov, G Kotov, N Stamenov, T Dikov, A Iliev
Acta Histochemica 2020
Myocardial‐Infarction‐Responsive Smart Hydrogels Targeting Matrix Metalloproteinase for On‐Demand Growth Factor Delivery
C Fan, J Shi, Y Zhuang, L Zhang, L Huang, W Yang, B Chen, Y Chen, Z Xiao, H Shen, Y Zhao, J Dai
Advanced materials (Deerfield Beach, Fla.) 2019
High-content screening assay-based discovery of paullones as novel podocyte-protective agents
HW Lee, E Arif, MM Altintas, K Quick, S Maheshwari, A Plezia, A Mahmood, J Reiser, D Nihalani, V Gupta
American journal of physiology. Renal physiology 2018
Expression of Cathepsin L and Its Intrinsic Inhibitors in Glomeruli of Rats With Puromycin Aminonucleoside Nephrosis
A Kubo, I Shirato, T Hidaka, M Takagi, Y Sasaki, K Asanuma, K Ishidoh, Y Suzuki
Journal of Histochemistry & Cytochemistry 2018
Postnatal podocyte gain: Is the jury still out?
VG Puelles, MJ Moeller
Seminars in Cell & Developmental Biology 2018
The Accumulation of Heparan Sulfate S-Domains in Kidney Transthyretin Deposits Accelerates Fibril Formation and Promotes Cytotoxicity
H Kameyama, K Uchimura, T Yamashita, K Kuwabara, M Mizuguchi, SC Hung, K Okuhira, T Masuda, T Kosugi, T Ohgita, H Saito, Y Ando, K Nishitsuji
The American Journal of Pathology 2018
Friends Turned Foes: Angiogenic Growth Factors beyond Angiogenesis
P Matkar, R Ariyagunarajah, H Leong-Poi, K Singh
Biomolecules 2017
Serum Response Factor Is Essential for Maintenance of Podocyte Structure and Function
B Guo, Q Lyu, OJ Slivano, R Dirkx, CK Christie, J Czyzyk, AF Hezel, AG Gharavi, EM Small, JM Miano
Journal of the American Society of Nephrology : JASN 2017
Cinaciguat ameliorates glomerular damage by reducing ERK1/2 activity and TGF-ß expression in type-1 diabetic rats
S Czirok, L Fang, T Radovits, G Szabó, G Szénási, L Rosivall, B Merkely, G Kökény
Scientific Reports 2017
Bi-nucleation of podocytes is uniformly accompanied by foot processes widening in renal disease
J Mühldorfer, E Pfister, M Büttner-Herold, M Klewer, K Amann, C Daniel
Nephrology Dialysis Transplantation 2017
Intramyocardial delivery of bFGF with a biodegradable and thermosensitive hydrogel improves angiogenesis and cardio-protection in infarcted myocardium
H Zhu, X Li, M Yuan, W Wan, M Hu, X Wang, X Jiang
Experimental and therapeutic medicine 2017
Ablation of FGFR2 in Fibroblasts Ameliorates Kidney Fibrosis after Ischemia/Reperfusion Injury in Mice
Z Xu, C Dai
Kidney Diseases 2017
FGF23 in kidney transplant: the strange case of Doctor Jekyll and Mister Hyde
G Cianciolo, M Cozzolino
Clinical Kidney Journal 2016
MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2
ML Yeung, Y Yao, L Jia, JF Chan, KH Chan, KF Cheung, H Chen, VK Poon, AK Tsang, KK To, MK Yiu, JL Teng, H Chu, J Zhou, Q Zhang, W Deng, SK Lau, JY Lau, PC Woo, TM Chan, S Yung, BJ Zheng, DY Jin, PW Mathieson, C Qin, KY Yuen
Nature Microbiology 2016
Role of Receptor Tyrosine Kinase Signaling in Renal Fibrosis
F Liu, S Zhuang
International journal of molecular sciences 2016
Origin and fate of the regenerating cells of the kidney
J Eymael, B Smeets
European Journal of Pharmacology 2016
Kidney Development, Disease, Repair and Regeneration
RP Scott, SE Quaggin
Kidney Development, Disease, Repair and Regeneration 2016
Glypican-5 Increases Susceptibility to Nephrotic Damage in Diabetic Kidney
K Okamoto, K Honda, K Doi, T Ishizu, D Katagiri, T Wada, K Tomita, T Ohtake, T Kaneko, S Kobayashi, M Nangaku, K Tokunaga, E Noiri
The American Journal of Pathology 2015
Renal targeted delivery of triptolide by conjugation to the fragment peptide of human serum albumin
Z Yuan, X Wu, J Mo, Y Wang, C Xu, LY Lim
European Journal of Pharmaceutics and Biopharmaceutics 2015
MiR-30a Inhibits the Epithelial—Mesenchymal Transition of Podocytes through Downregulation of NFATc3
R Peng, L Zhou, Y Zhou, Y Zhao, Q Li, D Ni, Y Hu, Y Long, J Liu, Z Lyu, Z Mao, Y Yuan, L Huang, H Zhao, G Li, Q Zhou
International journal of molecular sciences 2015
Involvement of cytokines in the modulation and progression of renal fibrosis induced by unilateral ureteral obstruction in C57BL/6 mice: effects of thalidomide and dexamethasone
LE Bersani-Amado, JA Dantas, MJ Damião, BA Rocha, JC Besson, RL Bastos, LN Silva, CA Bersani-Amado, RK Cuman
Fundamental & Clinical Pharmacology 2015
Pediatric Nephrology
ED Avner, WE Harmon, P Niaudet, N Yoshikawa, F Emma, S Goldstein
Pediatric Nephrology 2015
Signal transduction in podocytes--spotlight on receptor tyrosine kinases
J Reiser, S Sever, C Faul
Nature reviews. Nephrology 2014
The emergence of the glomerular parietal epithelial cell
SJ Shankland, B Smeets, JW Pippin, MJ Moeller
Nature Reviews Nephrology 2014
Mesenchymal stem cells protect podocytes from apoptosis induced by high glucose via secretion of epithelial growth factor
D Li, N Wang, L Zhang, Z Hanyu, B Xueyuan, B Fu, C Shaoyuan, W Zhang, S Xuefeng, R Li, X Chen
Stem Cell Research & Therapy 2013
Seldin and Giebisch's The Kidney
CJ Cooper, LD Dworkin, WL Henrich
Seldin and Giebisch's The Kidney 2013
Renal Heparan Sulfate Proteoglycans Modulate Fibroblast Growth Factor 2 Signaling in Experimental Chronic Transplant Dysfunction
K Katta, M Boersema, H Rienstra, S Adepu, JW Celie, R Mencke, G Molema, H Goor, JH Berden, G Navis, JL Hillebrands, J Born
The American Journal of Pathology 2013
Acid sphingomyelinase gene knockout ameliorates hyperhomocysteinemic glomerular injury in mice lacking cystathionine-β-synthase
KM Boini, M Xia, JM Abais, M Xu, C Li, PL Li
PloS one 2012
Parietal Epithelial Cells and Podocytes in Glomerular Diseases
B Smeets, MJ Moeller
Seminars in Nephrology 2012
Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes
L Fang, T Radovits, G Szabo, MM Mozes, L Rosivall, G Kokeny
Nephrology Dialysis Transplantation 2012
Acid Sphingomyelinase Gene Knockout Ameliorates Hyperhomocysteinemic Glomerular Injury in Mice Lacking Cystathionine-β-Synthase
KM Boini, M Xia, JM Abais, M Xu, C Li, PL Li, C Chatziantoniou
PloS one 2012
WT1-Dependent Sulfatase Expression Maintains the Normal Glomerular Filtration Barrier
VA Schumacher, U Schlotzer-Schrehardt, SA Karumanchi, X Shi, J Zaia, S Jeruschke, D Zhang, H Pavenstadt, A Drenckhan, K Amann, C Ng, S Hartwig, KH Ng, J Ho, JA Kreidberg, M Taglienti, B Royer-Pokora, X Ai
Journal of the American Society of Nephrology : JASN 2011
Common variation in GPC5 is associated with acquired nephrotic syndrome
K Okamoto, K Tokunaga, K Doi, T Fujita, H Suzuki, T Katoh, T Watanabe, N Nishida, A Mabuchi, A Takahashi, M Kubo, S Maeda, Y Nakamura, E Noiri
Nature Genetics 2011
Controlled-Release Basic Fibroblast Growth Factor for Peripheral Artery Disease: Comparison with Autologous Bone Marrow-Derived Stem Cell Transfer
G Takagi, M Miyamoto, S Tara, I Takagi, H Takano, M Yasutake, Y Tabata, K Mizuno
Tissue Engineering Part A 2011
Elevated Fibroblast Growth Factor 23 is a Risk Factor for Kidney Transplant Loss and Mortality
M Wolf, MZ Molnar, AP Amaral, ME Czira, A Rudas, A Ujszaszi, I Kiss, L Rosivall, J Kosa, P Lakatos, CP Kovesdy, I Mucsi
Journal of the American Society of Nephrology : JASN 2011
A conceptual framework for the molecular pathogenesis of progressive kidney disease
HW Schnaper, SC Hubchak, CE Runyan, JA Browne, G Finer, X Liu, T Hayashida
Pediatric Nephrology 2010
The Role of Heparanase in Diseases of the Glomeruli
M Szymczak, J Kuźniar, M Klinger
Archivum Immunologiae et Therapiae Experimentalis 2010
Hydrogen sulfide ameliorates hyperhomocysteinemia-associated chronic renal failure
U Sen, P Basu, OA Abe, S Givvimani, N Tyagi, N Metreveli, KS Shah, JC Passmore, SC Tyagi
American journal of physiology. Renal physiology 2009
Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats
T Okada, T Sakaguchi, I Hatamura, F Saji, S Negi, H Otani, Y Muragaki, H Kawachi, T Shigematsu
Clinical and Experimental Nephrology 2009
A urinary biomarker profile for children with HIV-associated renal diseases
AA Soler-García, NY Rakhmanina, PC Mattison, PE Ray
Kidney International 2009
Hydrogen sulfide ameliorates hyperhomocysteinemia-associated chronic renal failure
U Sen, P Basu, OA Abe, S Givvimani, N Tyagi, N Metreveli, KS Shah, JC Passmore, SC Tyagi
American journal of physiology. Renal physiology 2009
Role of basic fibroblast growth factor (FGF-2) in diabetic nephropathy and mechanisms of its induction by hyperglycemia in human renal fibroblasts
R Vasko, M Koziolek, M Ikehata, MP Rastaldi, K Jung, H Schmid, M Kretzler, GA Müller, F Strutz
American journal of physiology. Renal physiology 2009
Late-onset endothelin receptor blockade in hypertensive heterozygous REN-2 transgenic rats
Z Vernerová, HJ Kramer, A Bäcker, L Červenka, M Opočenský, Z Husková, Z Vaňourková, V Eis, VČ Chábová, V Tesař, J Malý, I Vaněčková
Vascular Pharmacology 2008
Intramyocardial injection of low-dose basic fibroblast growth factor or vascular endothelial growth factor induces angiogenesis in the infarcted rabbit myocardium
I Bougioukas, V Didilis, P Ypsilantis, A Giatromanolaki, E Sivridis, T Lialiaris, D Mikroulis, C Simopoulos, G Bougioukas
Cardiovascular Pathology 2007
The management of CKD: A look into the future
A Khwaja, ME Kossi, J Floege, ME Nahas
Kidney International 2007
Revascularization of trachea in lung and tracheal transplantation
R Nakanishi
Clinical Transplantation 2007
Cardiovascular gene delivery: The good road is awaiting☆
LP Brewster, EM Brey, HP Greisler
Advanced Drug Delivery Reviews 2006
The podocyte's response to injury: Role in proteinuria and glomerulosclerosis
SJ Shankland
Kidney International 2006
Immunolocalization of fibroblast growth factor-1 (FGF-1), its receptor (FGFR-1), and fibroblast-specific protein-1 (FSP-1) in inflammatory renal disease
M Rossini, B Cheunsuchon, E Donnert, L Ma, JW Thomas, EG Neilson, AB Fogo
Kidney International 2005
Podocyte damage damages podocytes: autonomous vicious cycle that drives local spread of glomerular sclerosis
I Ichikawa, J Ma, M Motojima, T Matsusaka
Current Opinion in Nephrology and Hypertension 2005
Heparanase inhibition reduces proteinuria in a model of accelerated anti-glomerular basement membrane antibody disease
V Levidiotis, C Freeman, C Tikellis, ME Cooper, DA Power
Nephrology 2005
Apoptosis in glomerulonephritis
J Hughes, JS Savill
Current Opinion in Nephrology and Hypertension 2005
Cellular Response to Injury in Membranous Nephropathy
M Nangaku, SJ Shankland, WG Couser
Journal of the American Society of Nephrology : JASN 2005
Protein-, gene-, and cell-based therapeutic angiogenesis for the treatment of myocardial ischemia
M Ruel, J Song, FW Sellke
Molecular and Cellular Biochemistry 2004
Viable Podocytes Detach in Experimental Diabetic Nephropathy: Potential Mechanism Underlying Glomerulosclerosis
AT Petermann, J Pippin, R Krofft, M Blonski, S Griffin, R Durvasula, SJ Shankland
Nephron Experimental Nephrology 2004
Differential Expression of D-Type Cyclins in Podocytes in Vitro and in Vivo
A Petermann, K Hiromura, J Pippin, M Blonski, WG Couser, J Kopp, P Mundel, SJ Shankland
The American Journal of Pathology 2004
Glomerulosclerosis: A paraneoplastic phenomenon?
S Loi, GJ Perry, H Standish, J Dowling
Nephrology 2004
A 20-year history of childhood HIV-associated nephropathy
PE Ray, L Xu, T Rakusan, XH Liu
Pediatric Nephrology 2004
A novel HIV-1 transgenic rat model of childhood HIV-1-associated nephropathy
PE Ray, XH Liu, LR Robinson, W Reid, L Xu, JW Owens, OD Jones, F Denaro, HG Davis, JL Bryant
Kidney International 2003
Vascular growth factors and angiogenesis in cardiac surgery
FW Sellke, M Ruel
The Annals of Thoracic Surgery 2003
Activation and cellular localization of the p38 and JNK MAPK pathways in rat crescentic glomerulonephritis
C Stambe, RC Atkins, PA Hill, DJ Nikolic-Paterson
Kidney International 2003
Mitotic cell cycle proteins increase in podocytes despite lack of proliferation
AT Petermann, J Pippin, K Hiromura, T Monkawa, R Durvasula, WG Couser, J Kopp, SJ Shankland
Kidney International 2003
Angiogenic protein therapy
M Ruel, FW Sellke
Seminars in Thoracic and Cardiovascular Surgery 2003
Cell Biology of the Glomerular Podocyte
H Pavenstädt, W Kriz, M Kretzler
Physiological reviews 2003
A “Molecular Toolbox” for the Nephrologist
SE Quaggin
Journal of the American Society of Nephrology : JASN 2002
Selective modulation of the secretion of proteinases and their inhibitors by growth factors in cultured differentiated podocytes
K Asanuma, I Shirato, K Ishidoh, E Kominami, Y Tomino
Kidney International 2002
Podocyte is the major culprit accounting for the progression of chronic renal disease
W Kriz
Microscopy Research and Technique 2002
Basic Fibroblast Growth Factor and Shiga Toxin–O157:H7–Associated Hemolytic Uremic Syndrome
PI Tarr
Journal of the American Society of Nephrology : JASN 2002
Caught flat-footed: Podocyte damage and the molecular bases of focal glomerulosclerosis
Dontscho Kerjaschki
Journal of Clinical Investigation 2001
Podocyte injury underlies the progression of focal segmental glomerulosclerosis in the fa/fa Zucker rat
N Gassler, M Elger, B Kränzlin, W Kriz, N Gretz, B Hähnel, H Hosser, I Hartmann
Kidney International 2001
Fibroblast growth factor receptors and their ligands in the adult rat kidney
B Cancilla, A Davies, JA Cauchi, GP Risbridger, JF Bertram
Kidney International 2001
Podocyte expression of the CDK-inhibitor p57 during development and disease
K Hiromura, LA Haseley, P Zhang, T Monkawa, R Durvasula, AT Petermann, CE Alpers, P Mundel, SJ Shankland
Kidney International 2001
Lupus nephritis: Lessons from experimental animal models
CJ Peutz-Kootstra, E Heer, PJ Hoedemaeker, CK Abrass, JA Bruijn
Journal of Laboratory and Clinical Medicine 2001
Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat
YH Kim, M Goyal, D Kurnit, B Wharram, J Wiggins, L Holzman, D Kershaw, R Wiggins
Kidney International 2001
Regulation of renal proximal tubular epithelial cell fibroblast growth factor-2 generation by heparin
SG Jones, K Morrisey, AO Phillips
American Journal of Kidney Diseases 2001
Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease
TD Henry, K Rocha-Singh, JM Isner, DJ Kereiakes, FJ Giordano, M Simons, DW Losordo, RC Hendel, RO Bonow, SM Eppler, TF Zioncheck, EB Holmgren, ER McCluskey
American Heart Journal 2001
Hyperphagia as a Mediator of Renal Disease Initiation in Obese Zucker Rats
FT Stevenson, CM Wheeldon, MD Gades, H Goor, JS Stern
Obesity research 2001
Basic fibroblast growth factor expression is increased in human renal fibrogenesis and may mediate autocrine fibroblast proliferation
F Strutz, M Zeisberg, B Hemmerlein, B Sattler, K Hummel, V Becker, GA Müller
Kidney International 2000
Estrogen worsens incipient hypertriglyceridemic glomerular injury in the obese Zucker rat
FT Stevenson, CM Wheeldon, MD Gades, GA Kaysen, JS Stern, HV Goor
Kidney International 2000
Fibrosis and angiogenesis
R Kalluri, VP Sukhatme
Current Opinion in Nephrology and Hypertension 2000
Angiogenic Therapy for the Chronically Ischemic Lower Limb in a Rabbit Model
R Baffour, JL Garb, J Kaufman, J Berman, SW Rhee, MA Norris, P Friedmann
Journal of Surgical Research 2000
Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis
SJ Shankland, G Wolf
American journal of physiology. Renal physiology 2000
Nephrotic Syndrome and Plasmapheresis
GE Russo, M Bonello, B Bauco, M Bosco, M Tedaldi, MF Bisciglia, E Vitaliano, R Russo, AD Paola
The International Journal of Artificial Organs 2000
Vascular Endothelial Growth Factor Enhances Glomerular Capillary Repair and Accelerates Resolution of Experimentally Induced Glomerulonephritis
T Ostendorf, U Kunter, F Eitner, A Loos, H Regele, D Kerjaschki, DD Henninger, N Janjic, J Floege
Journal of Clinical Investigation 1999
Cell cycle regulatory proteins in glomerular disease
SJ Shankland
Kidney International 1999
Localization of fibroblast growth factor-2 (basic FGF) and FGF receptor-1 in adult human kidney 1
J Floege, KL Hudkins, F Eitner, Y Cui, RS Morrison, MA Schelling, CE Alpers
Kidney International 1999
Origin of hyperplastic epithelial cells in idiopathic collapsing glomerulopathy
I Kihara, E Yaoita, K Kawasaki, T Yamamoto, M Hara, T Yanagihara
Histopathology 1999
Heparin-binding epidermal growth factor-like growth factor is expressed in the adhesive lesions of experimental focal glomerular sclerosis
K Paizis, G Kirkland, T Khong, M Katerelos, S Fraser, J Kanellis, DA Power
Kidney International 1999
Vascular Endothelial Growth Factor Enhances Glomerular Capillary Repair and Accelerates Resolution of Experimentally Induced Glomerulonephritis
T Ostendorf, U Kunter, F Eitner, A Loos, H Regele, D Kerjaschki, DD Henninger, N Janjic, J Floege
Journal of Clinical Investigation 1999
The role of the podocyte in glomerulosclerosis
W Kriz, KV Lemley
Current Opinion in Nephrology and Hypertension 1999
Role of extracellular matrix and Ras in regulation of glomerular epithelial cell proliferation
AV Cybulsky, AJ McTavish, J Papillon, T Takano
The American Journal of Pathology 1999
Extracellular matrix as a determinant of signaling responses in glomerular epithelial cells
AV Cybulsky
Kidney International 1999
FGF-2: Specific activity in kidney?
J Barasch
Kidney International 1999
Augmentation of kidney injury by basic fibroblast growth factor or platelet-derived growth factor does not induce progressive diabetic nephropathy in the Goto Kakizaki model of non-insulin-dependent diabetes
SG Riley, R Steadman, JD Williams, J Floege, AO Phillips
Journal of Laboratory and Clinical Medicine 1999
New aspects of podocyte structure, function, and pathology
W Kriz, N Kobayashi, M Elger
Clinical and Experimental Nephrology 1998
Renal microvascular assembly and repair: Power and promise of molecular definition
T Takahashi, U Huynh-Do, TO Daniel
Kidney International 1998
Heparin-binding epidermal growth factor-like growth factor in experimental models of membranous and minimal change nephropathy
K Paizis, G Kirkland, M Polihronis, M Katerelos, J Kanellis, DA Power
Kidney International 1998
Renal microvascular assembly and repair: Power and promise of molecular definition
T Takahashi, U Huynh-Do, TO Daniel
Kidney International 1998
Apoptosis in Kidneys of Endothelin-1 Transgenic Mice
B Hocher, P Rohmeiss, C Thöne-Reineke, A Schwarz, V Burst, F der Woude, C Bauer, NA Theuring
Journal of Cardiovascular Pharmacology 1998
Cyclin kinase inhibitors are increased during experimental membranous nephropathy: Potential role in limiting glomerular epithelial cell proliferation in vivo
SJ Shankland, J Floege, SE Thomas, M Nangaku, C Hugo, J Pippin, K Henne, DM Hockenberry, RJ Johnson, WG Couser
Kidney International 1997
Role of interleukin-6 in mediating mesangial cell proliferation and matrix production in vivo
F Eitner, R Westerhuis, M Burg, B Weinhold, HJ Gröne, T Ostendorf, U Rüther, KM Koch, AJ Rees, J Floege
Kidney International 1997
Age-related glomerulosclerosis and interstitial fibrosis in Milan normotensive rats: A podocyte disease
J Floege, B Hackmann, V Kliem, W Kriz, CE Alpers, RJ Johnson, KW Kühn, KM Koch, R Brunkhorst
Kidney International 1997
Expression of fibroblast growth factors and their receptors in rat glomeruli
MD Ford, J Cauchi, U Greferath, JF Bertram
Kidney International 1997
Changes in glomerular epithelial cells induced by FGF2 and FGF2 neutralizing antibody in puromycin aminonucleoside nephropathy
T Sasaki, Y Jyo, N Tanda, Y Kawakami, T Nohno, H Tamai, G Osawa
Kidney International 1997
Cell-cycle control and renal disease
SJ Shankland
Kidney International 1997
Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis
S Breiteneder-Geleff, K Matsui, A Soleiman, P Meraner, H Poczewski, R Kalt, G Schaffner, D Kerjaschki
The American Journal of Pathology 1997
Extracellular Matrix Is Required for MAP Kinase Activation and Proliferation of Rat Glomerular Epithelial Cells
AV Cybulsky, AJ McTavish
Biochemical and Biophysical Research Communications 1997
Glomerular podocyte density as a marker predicting the outcome of patients with IgA nephropathy
Y Takahashi
Juntendo Medical Journal 1997
Progressive renal failure--inability of podocytes to replicate and the consequences for development of glomerulosclerosis
J Floege, RJ Johnson, CE Alpers, S Fatemi-Nainie, CA Richardson, K Gordon, WG Couser
Nephrology Dialysis Transplantation 1996
Progressive renal failure--inability of podocytes to replicate and the consequences for development of glomerulosclerosis
J Floege, RJ Johnson, CE Alpers, S Fatemi-Nainie, CA Richardson, K Gordon, WG Couser
Nephrology Dialysis Transplantation 1996
Cyclins, Cdks, and cyclin kinase inhibitors
J Floege, E Eng, BA Young, CE Alpers, TB Barrett, DF Bowen-Pope, RJ Johnson
Journal of Clinical Investigation 1994
Cyclins, Cdks, and cyclin kinase inhibitors
J Floege, E Eng, BA Young, CE Alpers, TB Barrett, DF Bowen-Pope, RJ Johnson
Kidney International 1994
Cyclins, Cdks, and cyclin kinase inhibitors
J Floege, E Eng, BA Young, CE Alpers, TB Barrett, DF Bowen-Pope, RJ Johnson
Kidney International 1994

← Previous 1 2 3 4 5 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 2 patents
14 readers on Mendeley
See more details